Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease.

ABSTRACT: Cardiac rehabilitation (CR) in patients with coronary heart disease (CHD) increases adherence to a healthy lifestyle and to secondary preventive medication. A notable example of such medication is lipid-lowering therapy (LLT). LLT during CR improves quality of life and prognosis, and thus is particularly relevant for patients with diabetes mellitus, which is a major risk factor for CHD. A prospective, multicenter registry study with patients from six rehabilitation centers in Germany. During CR, 1100 patients with a minimum age of 18 years and CHD documented by coronary angiography were included in a LLT registry. In 369 patients (33.9%), diabetes mellitus was diagnosed. Diabetic patients were older (65.5 ± 9.0 vs. 62.2 ± 10.9 years, p < 0.001) than nondiabetic patients and were more likel

SUBMITTER: Wittlinger T 

PROVIDER: S-EPMC8470282 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature